Induced Abortion
Conditions
Interventions
Experimental group:Different doses of oliceridine are administered according to the sequential trial method.
Sponsors
Weifang People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged 18–65 years, male or female, with a body mass index (BMI) of 18–30 kg/m^2; 2.American Society of Anesthesiologists (ASA) physical status I–II; 3.Patients requiring painless induced abortion; 4.Those who fully understand, voluntarily participate in the study, and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Those who are allergic or contraindicated to the drugs involved in this trial; 2.Patients with hepatic or renal insufficiency; 3.Patients with difficult airway management, such as limited mouth opening or a modified Mallampati score of grade IV; 4.Those with mental or cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether intraoperative body movement occurs, or the increases in heart rate (HR) and mean arterial pressure (MAP) exceed 20% of the baseline values.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative hemodynamic changes;Operation time ;Recovery time;Dose of drug ; | — |
Countries
China
Contacts
Public ContactFanceng Ji
Weifang People's Hospital, Shandong Province
Outcome results
None listed